Tumor-conditioned medium (TCM) obtained from the human SK-MEL melanoma cell line did not affect the ability of human DCs generated from CD14+ monocytes to stimulate allogeneic T cells (Fig. 2c). The gene discussed is CD14; the disease is melanoma.